From Clinical Trial Efficacy to Public Health Impact: A Plan for Accelerating Access to Injectable Lenacapavir for PrEP
This plan provides a broad view of all the moving parts and identifies actions and actors responsible for ensuring time is not wasted and opportunity not squandered.
- Topics:
- Accelerating Product Innovation
- Advocating for Health Equity
- Tracking and Translating the Field
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!